Grifols, the Spanish biotech firm, has taken a 20 percent stake in a California- based laboratory for $50 million. The deal is among the latest involving overseas businesses taking stakes in … [Read more...]
FUNDING
Quanterix Raises $46 Million to Fuel Expansion of Clinical Diagnostics
March 28, 2016
By Stephanie Murg, Managing Director, G2 Intelligence A fresh infusion of capital is set to fuel continued growth at Quanterix Corporation (Lexington, Mass.), which specializes in "high-definition … [Read more...]
AltheaDX Raises $30 Million, Announces New Tests
February 1, 2016
AltheaDX, a California-based lab that focuses on pharmacogenetic testing, has raised $30 million in a third round of financing. The money comes from several investors, including WUXi Healthcare … [Read more...]
Laboratory M&A in 2015: Flat but With Possibilities Moving Forward
February 1, 2016
When it came to mergers and acquisitions in the laboratory arena, 2015 has proven to be pretty much more of the same. Altogether, there were 29 transactions announced during the 2015 calendar year, … [Read more...]
AltheaDX Raises $30 Million, Announces New Tests
January 21, 2016
AltheaDX, a California-based lab that focuses on pharmacogenetic testing, has raised $30 million in a third round of financing. The money comes from several investors, including WUXi Healthcare … [Read more...]
Outlook for Medium-Size Labs Continues to Show Promise
November 19, 2015
The outlook for the mid-size and smaller publicly traded laboratories appears to be bright. Most reported gains in earnings or revenue, or significant capital infusions in the most recent quarter and … [Read more...]
Troubled Calloway Laboratories Shut Its Doors
October 28, 2015
Calloway has gone away. The troubled Calloway Laboratories abruptly shut its doors on Oct. 16. The closure of the Woburn, Mass.-based lab put about 240 employees out of work. Calloway Chief Executive … [Read more...]
CardioDx Inks Draw Deal With Quest
October 9, 2015
CardioDx, a California-based molecular laboratory that specializes in cardiac assays, has entered into a blood draw agreement with national lab giant Quest Diagnostics. Under the terms of the … [Read more...]
Exosome Raises Second Round Funding, Close to Launching Cancer Tests
September 17, 2015
Exosome Diagnostics has continued on its capital raising roll, bringing in another $17.6 million in financing, and its series B total to $44.7 million. The latest round was funded by Forbion Capital … [Read more...]
Laboratory M&A: Most of the Smaller Players Have Been Absorbed, Leading to Fewer, But Bigger Deals
September 3, 2015
Fewer deals. Bigger pricetags. That in a nutshell sums up the merger and acquisition activity in the laboratory sector during the first half of 2015. Altogether, there were 10 deals involving labs … [Read more...]
